Keck School Faculty

 
< Back to Index
Biraj Mahato

Biraj Mahato

Assistant Professor of Research Ophthalmology
Medicine
4640 West Sunset Blvd Off Campus Los Angeles

Contact

bmahato@usc.edu

Glaucoma Research Foundation: Grant award, 2019

: Cell Symposium Support Award, 2018

CSIR-IICB: Travel award to Gordon Research Conference, 2010

CSIR, Govt. of India : CSIR-Senior Research Fellowship, 2008

IIT: Graduate Aptitude Test in Engineering (GATE), 2006

CSIR, Govt. of India: CSIR-Junior Research Fellowship, 2006

Pharmacologic fibroblast reprogramming into photoreceptors restores vision Nature. 2020 05; 581(7806):83-88. . View in PubMed

Inhibition of Noncanonical Murine Double Minute 2 Homolog Abrogates Ocular Inflammation through NF-? B Suppression. Am J Pathol. 2018 09; 188(9):2087-2096.. View in PubMed

Stem Cells. 2014 Nov; 32(11):2880-92. . View in PubMed

Vesicular transport of a ribonucleoprotein to mitochondria Biol Open. 2014 Oct 17; 3(11):1083-91. . View in PubMed

Inhibition of protein kinase C signaling maintains rat embryonic stem cell pluripotency J Biol Chem. 2013 Aug 23; 288(34):24351-62. . View in PubMed

Mitochondrial gene therapy: The tortuous path from bench to bedside Mitochondrion. 2011 Nov; 11(6):839-44. . View in PubMed

RNA-mediated restoration of mitochondrial function in cells harboring a Kearns Sayre Syndrome mutation Mitochondrion. 2011 Jul; 11(4):564-74. . View in PubMed

Targeted mRNA degradation by complex-mediated delivery of antisense RNAs to intracellular human mitochondria Hum Mol Genet. 2008 May 01; 17(9):1292-8. . View in PubMed

Dr. Biraj Mahato earned his PhD in Molecular and Cellular Biology from the CSIR-Indian Institute of Chemical Biology (Jadavpur University), India. He completed his postdoctoral training in Stem cell biology and Regenerative medicine from KU Medical Center, UPenn and UNT Health Science Center. Dr. Mahato has extensive expertise in diverse biological fields such as cellular reprogramming, stem cell biology, retinal regeneration, and mitochondrial biology. Dr. Mahato’s prior research demonstrated a facile small molecule-based method to obtain retinal photoreceptor like cells from skin fibroblasts. Strikingly, these chemically induced photoreceptors were shown to restore vision in blind animal models (rd1). Moreover, his research showed how mitochondrial function and cellular energy metabolism balances pluripotency in embryonic stem cells.

Dr. Mahato’s laboratory currently focused on the following areas: (i) Development of novel regenerative cell-based therapies for ophthalmic neurodegenerative diseases. (ii) Molecular and functional analysis of photoreceptors (rod and cone) and retinal ganglion cells for their therapeutic application to cure blindness. (iii) In vivo retinal regeneration for visual function improvement. (iii) Translation of clinically observed correlations into a mechanistic understanding of the physical and biological underpinning of neurological disorders that affect both the retina and optic nerve.
sc ctsi logoPowered by SC CTSI